Skip to main content
H 7816Health Insurance

Insurance - Accident and Sickness Insurance Policies

Pharmacy benefit managers must provide patients and doctors with written, medically justified reasons for any prescription drug coverage denials.

Introduced
Population
Affected
72
Introduced Feb 26, 2026Committee House Health & Human Services

Plain-English Summary

This legislation mandates that Pharmacy Benefit Managers (PBMs) provide a written explanation whenever they deny coverage for a prescription drug. This notice must be delivered simultaneously to the patient and the prescribing doctor. The explanation requires a medically sound justification based on recognized clinical standards and must include the name and license information of the licensed medical professional who reviewed the decision. This requirement applies to various insurance policies, including accident, sickness, nonprofit hospital service corporations, and health maintenance organizations.

For younger readers

Sometimes, when a doctor orders medicine for a sick person, the insurance company says "no." This bill says that the people managing the medicine lists (called Pharmacy Benefit Managers) cannot just say "no" without a good reason. They must send a letter to the doctor and the patient explaining exactly why the medicine was denied. A real doctor or pharmacist must check the decision, and the letter has to explain the medical reason clearly so the patient knows what is happening.

Who & Where It Applies

Impacted groups
PatientsPharmacy Benefit ManagersPhysicians and Prescribing ProvidersPharmacistsHealth Insurance Companies
Impacted communities
All

Constitutional & Fiscal Check

None Likely

Estimated cost
None
Estimated revenue
None

Bill Analysis

Both viewpoints
For Progressives
  • Increases transparency and corporate accountability by forcing Pharmacy Benefit Managers to provide specific, evidence-based reasons for denying care, preventing arbitrary refusals.
  • Empowers patients and healthcare providers to advocate for necessary treatment by ensuring they have the detailed information required to file appeals against insurance denials.
  • Ensures that decisions regarding medication access are reviewed by licensed medical professionals rather than purely administrative personnel or automated systems.
  • The implementation date is delayed until January 1, 2027, leaving patients vulnerable to opaque denial practices for several more years.
  • While it requires an explanation for denials, it does not explicitly prohibit denials based on cost-saving measures if they can be technically justified by clinical standards.
  • Does not address the underlying issue of high pharmaceutical costs or the profit-driven nature of PBMs, serving only as a procedural reform rather than a systemic overhaul.
For Conservatives
  • Ensures that consumers receive the services they paid for by requiring insurance entities to justify why they are not fulfilling a coverage request.
  • Provides doctors with the necessary information to make informed decisions and challenge bureaucratic interference in the doctor-patient relationship.
  • Promotes clarity in contractual obligations between insurers and policyholders, reducing ambiguity in service delivery.
  • Imposes new government regulations on private businesses, dictating specific operational procedures and communication methods for Pharmacy Benefit Managers.
  • Could potentially increase administrative costs for insurance companies and PBMs, which might be passed on to consumers in the form of higher premiums.
  • Interferes with the free market by mandating specific staffing requirements (licensed professionals) for internal business decisions regarding coverage.

Votes

Loading votes...

Full Bill Text

Changes to existing Rhode Island law · 76 additions

SECTION 1. Chapter 27-18 of the General Laws entitled "Accident and Sickness Insurance Policies" is hereby amended by adding thereto the following section: 27-18-96. Coverage denial justification and notification.

(a) Notwithstanding any other provision of law, a pharmacy benefit manager as defined in § 27-18-33.2 shall not deny coverage for a prescription drug without first providing a written notice containing a medically sound justification for the denial, delivered simultaneously to both the prescribing provider and the patient. The notice shall include sufficient detail to permit the provider and patient to understand the basis for denial and, if appropriate, submit an appeal or request for prior authorization.

(1) Medical oversight requirement. Any medically sound justification required under this section must be provided or reviewed by a licensed physician, licensed pharmacist, or other health care professional authorized under Rhode Island law to provide such clinical determinations, and the name and license information of the reviewing professional must be included in the written notice.

(2) Definition of medically sound justification. For purposes of this section, "medically sound justification" means a reason based on recognized clinical standards or evidence-based guidelines appropriate to the patient’s condition.

(3) Plan compliance. Nothing in this section shall prevent a pharmacy benefit manager from denying coverage in accordance with the terms of the insurance plan or prescription drug benefit contract; provided that, the written justification requirement and medical oversight requirements are met.

SECTION 2. Chapter 27-19 of the General Laws entitled "Nonprofit Hospital Service Corporations" is hereby amended by adding thereto the following section: 27-19-88. Coverage denial justification and notification.

(a) Notwithstanding any other provision of law, a pharmacy benefit manager as defined in § 27-19-26.2 shall not deny coverage for a prescription drug without first providing a written notice containing a medically sound justification for the denial, delivered simultaneously to both the prescribing provider and the patient. The notice shall include sufficient detail to permit the provider and patient to understand the basis for denial and, if appropriate, submit an appeal or request for prior authorization.

(1) Medical oversight requirement. Any medically sound justification required under this section must be provided or reviewed by a licensed physician, licensed pharmacist, or other health care professional authorized under Rhode Island law to provide such clinical determinations, and the name and license information of the reviewing professional must be included in the written notice.

(2) Definition of medically sound justification. For purposes of this section, "medically sound justification" means a reason based on recognized clinical standards or evidence-based guidelines appropriate to the patient’s condition.

(3) Plan compliance. Nothing in this section shall prevent a pharmacy benefit manager from denying coverage in accordance with the terms of the insurance plan or prescription drug benefit contract; provided that, the written justification requirement and medical oversight requirements are met.

SECTION 3. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service Corporations" is hereby amended by adding thereto the following section: 27-20-84. Coverage denial justification and notification.

(a) Notwithstanding any other provision of law, a pharmacy benefit manager as defined in § 27-20-23.2 shall not deny coverage for a prescription drug without first providing a written notice containing a medically sound justification for the denial, delivered simultaneously to both the prescribing provider and the patient. The notice shall include sufficient detail to permit the provider and patient to understand the basis for denial and, if appropriate, submit an appeal or request for prior authorization.

(1) Medical oversight requirement. Any medically sound justification required under this section must be provided or reviewed by a licensed physician, licensed pharmacist, or other health care professional authorized under Rhode Island law to provide such clinical determinations, and the name and license information of the reviewing professional must be included in the written notice.

(2) Definition of medically sound justification. For purposes of this section, "medically sound justification" means a reason based on recognized clinical standards or evidence-based guidelines appropriate to the patient’s condition.

(3) Plan compliance. Nothing in this section shall prevent a pharmacy benefit manager from denying coverage in accordance with the terms of the insurance plan or prescription drug benefit contract; provided that, the written justification requirement and medical oversight requirements are met.

SECTION 4. Chapter 27-41 of the General Laws entitled "Health Maintenance Organizations" is hereby amended by adding thereto the following section: 27-41-101. Coverage denial justification and notification.

(a) Notwithstanding any other provision of law, a pharmacy benefit manager as defined in § 27-41-38.2 shall not deny coverage for a prescription drug without first providing a written notice containing a medically sound justification for the denial, delivered simultaneously to both the prescribing provider and the patient. The notice shall include sufficient detail to permit the provider and patient to understand the basis for denial and, if appropriate, submit an appeal or request for prior authorization.

(1) Medical oversight requirement. Any medically sound justification required under this section must be provided or reviewed by a licensed physician, licensed pharmacist, or other health care professional authorized under Rhode Island law to provide such clinical determinations, and the name and license information of the reviewing professional must be included in the written notice.

(2) Definition of medically sound justification. For purposes of this section, "medically sound justification" means a reason based on recognized clinical standards or evidence-based guidelines appropriate to the patient’s condition.

(3) Plan compliance. Nothing in this section shall prevent a pharmacy benefit manager from denying coverage in accordance with the terms of the insurance plan or prescription drug benefit contract; provided that, the written justification requirement and medical oversight requirements are met.

SECTION 5. This act shall take effect on January 1, 2027.